Penn State Launches $750K Network to Guide Pennsylvania Counties in Spending $1.7 Billion Opioid Settlement

Pennsylvania will receive more than $1.7 billion in opioid settlement funds over the next two decades, divided among all 67 counties—but county leaders controlling 70% of those dollars have largely been on their own when deciding how to spend them. That changed this week when Penn State University announced a $750,000 federally funded initiative to coordinate data, evidence, and community expertise statewide.

The Pennsylvania Addiction Action Network, housed within Penn State's Consortium on Substance Use and Addiction, will collect county-level data on overdose deaths, emergency department visits, youth substance use trends, and drug-related crime, then analyze and translate those metrics into decision-making guidance for local policymakers. The funding comes from the fiscal year 2026 Consolidated Appropriations Act and reflects advocacy by Senators John Fetterman and Dave McCormick.

Pennsylvania's Overdose Reality

In 2023, Pennsylvania recorded 4,719 overdose deaths—83% of them opioid-related, according to the state Department of Health. The settlement funds, negotiated with pharmaceutical manufacturers and distributors, are intended to reduce those deaths and other harms by supporting prevention, treatment, harm reduction, and recovery services. But with hundreds of millions arriving annually in the early years before payments taper in the 2030s, counties face pressure to spend strategically.

Many lack the internal capacity to evaluate which interventions work. Some rural counties have no addiction medicine specialists. Others struggle to coordinate between behavioral health agencies, law enforcement, hospitals, and community organizations. Gaps in data infrastructure mean baseline metrics are unclear: How many people need medication-assisted treatment? Where are naloxone distribution deserts? Which neighborhoods show rising overdose rates despite existing programs?

Joel Segel, associate professor of health policy and administration at Penn State and director of the Consortium on Substance Use and Addiction, described the network as bringing "data, evidence, and analysis to decision-makers" while convening stakeholders to "identify opportunities for shared understanding and coordinated solutions."

A Statewide Data Hub

The Pennsylvania Addiction Action Network will function as an intermediary between county governments and the academic institutions providing technical assistance. Penn State faculty will lead the effort, joined by experts at the University of Pittsburgh and Temple University, as well as Glenn Sterner—an associate professor of criminal justice at the University of Kentucky and former Penn State faculty member with deep Pennsylvania ties.

Counties will contribute data on key indicators. The network will aggregate those numbers, analyze patterns across regions, and generate publicly accessible reports. The aim is to show, for example, whether medication-assisted treatment capacity in one county could inform planning in a neighboring rural area, or whether syringe service programs funded in Philadelphia offer lessons for midsize cities like Reading or Harrisburg.

Michele Denk, executive director of the Pennsylvania Association of County Drug and Alcohol Administrators, called the partnership "a shared commitment to abating the opioid crisis" that "will increase technical assistance opportunities available to counties as they determine the most effective ways to spend opioid settlement funds."

Andrew Read, senior vice president for research at Penn State, emphasized the university's role: "As Pennsylvania's sole land-grant institution, we are uniquely qualified to meet this moment." He pointed to Penn State's established relationships with county officials, state agencies, and community organizations across the commonwealth.

Beyond Technical Assistance

The network will host in-person and virtual workshops bringing together county leaders, state officials, Penn State faculty, staff, and students. These gatherings are designed for real-time sharing of strategies, innovations, and evidence-based practices. Undergraduate and graduate students will participate as part of their training, positioning them to become the next generation of substance use policy and evaluation experts.

Technical assistance will extend beyond data analysis. The network will offer guidance on interventions funded through opioid settlement dollars—how to structure medication-assisted treatment programs, implement contingency management for stimulant use disorder, expand peer recovery services, or integrate harm reduction into existing public health frameworks. It will also help counties navigate regulatory requirements, Medicaid billing complexities, and workforce shortages.

Critically, the network recognizes that each county's crisis looks different. Philadelphia's fentanyl overdose deaths cluster in Kensington; rural counties in western Pennsylvania face methamphetamine-fentanyl polysubstance deaths compounded by treatment deserts. Urban counties may need supervised consumption sites; small-town counties need mobile medication-assisted treatment units. One-size-fits-all solutions fail.

Sterner noted that the effort "expands opportunities for applications and informed policy beyond Pennsylvania," suggesting that the model could inform how other states coordinate opioid settlement spending. Dozens of states face the same challenge: hundreds of millions arriving in fragmented county allocations without centralized coordination.

The Window Is Narrowing

Settlement payments are front-loaded, meaning annual amounts will decline significantly by the early 2030s. Counties must build infrastructure—residential treatment programs, medication-assisted treatment clinics, peer recovery networks, naloxone distribution systems—before the funding tapers. Infrastructure requires sustained operating budgets; settlement dollars can seed programs but rarely cover multi-decade salaries and facility maintenance.

The risk is that counties spend cautiously now, leaving millions undeployed, then face political narratives claiming settlement money was unnecessary. Alternatively, counties could fund popular but ineffective programs—like abstinence-only residential facilities with high dropout rates—because evidence-based harm reduction remains politically contentious.

The Pennsylvania Addiction Action Network aims to shift those dynamics by making data visible and evidence accessible. If a county sees that medication-assisted treatment reduces overdose deaths 50% in comparable communities, that becomes a benchmark. If peer recovery programs improve long-term retention, counties can weigh that against the cost of emergency department visits by people cycling in and out of short-term detox.

Pennsylvania is also navigating the federal policy whiplash that shook addiction services earlier this year. In January, the Trump administration briefly terminated nearly $2 billion in SAMHSA grants before reversing course within 24 hours. HHS Secretary Robert F. Kennedy Jr. subsequently announced a $100 million "Great American Recovery" initiative emphasizing "recovery and self-sufficiency" over harm reduction, framing naloxone distribution and housing-first models as "misguided." That ideological pivot created uncertainty even as overdose deaths nationwide declined 27% in 2024.

The Pennsylvania network represents a bet on localism: county leaders who understand their communities can make smarter decisions than distant federal mandates, but only if they have the data, training, and peer learning networks to do so.

What Success Looks Like

Success will be measured not just by dollars spent but by outcomes: fewer overdose deaths, more people retained in medication-assisted treatment, reduced emergency department visits for opioid withdrawal, expanded naloxone distribution reaching marginalized populations. It will also be measured by infrastructure that survives after settlement funds decline—clinics still operating in 2040, peer recovery organizations with stable funding, trained addiction medicine providers practicing in rural counties.

The County Commissioners Association of Pennsylvania has already partnered with Penn State, signaling buy-in from local government leaders. The Pennsylvania Opioid Misuse and Addiction Abatement Trust, which administers a portion of the settlement funds, is another key stakeholder. If the network succeeds in Pennsylvania, other states confronting the same coordination challenge may adopt similar models.

For now, the work begins with data collection, stakeholder convening, and the slower, harder task of translating evidence into policy. Pennsylvania recorded more than 12 overdose deaths per day in 2023. The settlement funds represent the largest public health investment in a generation—but only if counties use them wisely.